These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
284 related articles for article (PubMed ID: 22348060)
1. Association between polymorphisms in the promoter regions of matrix metalloproteinases (MMPs) and risk of cancer metastasis: a meta-analysis. Liu D; Guo H; Li Y; Xu X; Yang K; Bai Y PLoS One; 2012; 7(2):e31251. PubMed ID: 22348060 [TBL] [Abstract][Full Text] [Related]
2. Current evidence on the relationship between five polymorphisms in the matrix metalloproteinases (MMP) gene and lung cancer risk: a meta-analysis. Hu C; Wang J; Xu Y; Li X; Chen H; Bunjhoo H; Xiong W; Xu Y; Zhao J Gene; 2013 Mar; 517(1):65-71. PubMed ID: 23313298 [TBL] [Abstract][Full Text] [Related]
3. Polymorphisms in the promoter regions of matrix metalloproteinases 1 and 3 and cancer risk: a meta-analysis of 50 case-control studies. Peng B; Cao L; Wang W; Xian L; Jiang D; Zhao J; Zhang Z; Wang X; Yu L Mutagenesis; 2010 Jan; 25(1):41-8. PubMed ID: 19843588 [TBL] [Abstract][Full Text] [Related]
4. Meta-analysis of MMP2, MMP3, and MMP9 promoter polymorphisms and head and neck cancer risk. Zhang C; Li C; Zhu M; Zhang Q; Xie Z; Niu G; Song X; Jin L; Li G; Zheng H PLoS One; 2013; 8(4):e62023. PubMed ID: 23637955 [TBL] [Abstract][Full Text] [Related]
5. Association between promoters polymorphisms of matrix metalloproteinases and risk of digestive cancers: a meta-analysis. Li X; Qu L; Zhong Y; Zhao Y; Chen H; Daru L J Cancer Res Clin Oncol; 2013 Sep; 139(9):1433-47. PubMed ID: 23644699 [TBL] [Abstract][Full Text] [Related]
6. Meta-analysis of associations between four polymorphisms in the matrix metalloproteinases gene and gastric cancer risk. Yang TF; Guo L; Wang Q Asian Pac J Cancer Prev; 2014; 15(3):1263-7. PubMed ID: 24606450 [TBL] [Abstract][Full Text] [Related]
7. Meta-analysis of associations between polymorphisms in the promoter regions of matrix metalloproteinases and the risk of colorectal cancer. Liu D; Duan W; Guo H; Xu X; Bai Y Int J Colorectal Dis; 2011 Sep; 26(9):1099-105. PubMed ID: 21538057 [TBL] [Abstract][Full Text] [Related]
9. Genetic polymorphisms of MMP1, MMP3 and MMP7 gene promoter and risk of colorectal adenoma. Lièvre A; Milet J; Carayol J; Le Corre D; Milan C; Pariente A; Nalet B; Lafon J; Faivre J; Bonithon-Kopp C; Olschwang S; Bonaiti-Pellié C; Laurent-Puig P; BMC Cancer; 2006 Nov; 6():270. PubMed ID: 17125518 [TBL] [Abstract][Full Text] [Related]
10. Meta-analysis of association between matrix metalloproteinases 2, 7 and 9 promoter polymorphisms and cancer risk. Peng B; Cao L; Ma X; Wang W; Wang D; Yu L Mutagenesis; 2010 Jul; 25(4):371-9. PubMed ID: 20360147 [TBL] [Abstract][Full Text] [Related]
11. Current evidence on the relationships among five polymorphisms in the matrix metalloproteinases genes and prostate cancer risk. Gui J; Zhou H; Li S; Chen A; Liu Q; Zhu L; Mi Y Sci Rep; 2024 May; 14(1):11355. PubMed ID: 38762659 [TBL] [Abstract][Full Text] [Related]
13. Association Between Matrix Metalloproteinase-1, 2, 3 Polymorphisms and Oral Cancer Risk: A Meta-Analysis. Li Y; Wang Y; Sun H; Zhang Y; Li H; Cong X; Yin W; Song W Genet Test Mol Biomarkers; 2018 Aug; 22(8):456-464. PubMed ID: 30117779 [TBL] [Abstract][Full Text] [Related]
14. Polymorphisms of the promoter regions of matrix metalloproteinases genes MMP-1 and MMP-9 in breast cancer. Przybylowska K; Kluczna A; Zadrozny M; Krawczyk T; Kulig A; Rykala J; Kolacinska A; Morawiec Z; Drzewoski J; Blasiak J Breast Cancer Res Treat; 2006 Jan; 95(1):65-72. PubMed ID: 16267613 [TBL] [Abstract][Full Text] [Related]
15. Matrix metalloproteinases 1, 2, 3 and 9 functional single-nucleotide polymorphisms in idiopathic recurrent spontaneous abortion. Pereza N; Ostojić S; Volk M; Kapović M; Peterlin B Reprod Biomed Online; 2012 May; 24(5):567-75. PubMed ID: 22406112 [TBL] [Abstract][Full Text] [Related]
16. Matrix metalloproteinase 1, 3 and 12 polymorphisms and esophageal adenocarcinoma risk and prognosis. Bradbury PA; Zhai R; Hopkins J; Kulke MH; Heist RS; Singh S; Zhou W; Ma C; Xu W; Asomaning K; Ter-Minassian M; Wang Z; Su L; Christiani DC; Liu G Carcinogenesis; 2009 May; 30(5):793-8. PubMed ID: 19321798 [TBL] [Abstract][Full Text] [Related]
17. Association of a haplotype of matrix metalloproteinase (MMP)-1 and MMP-3 polymorphisms with renal cell carcinoma. Hirata H; Okayama N; Naito K; Inoue R; Yoshihiro S; Matsuyama H; Suehiro Y; Hamanaka Y; Hinoda Y Carcinogenesis; 2004 Dec; 25(12):2379-84. PubMed ID: 15319295 [TBL] [Abstract][Full Text] [Related]
18. Single nucleotide polymorphisms in MMP1 and MMP3 gene promoters as risk factor in head and neck squamous cell carcinoma. Zinzindohoué F; Blons H; Hans S; Loriot MA; Houllier AM; Brasnu D; Laccourreye O; Tregouet DA; Stucker I; Laurent-Puig P Anticancer Res; 2004; 24(3b):2021-6. PubMed ID: 15274394 [TBL] [Abstract][Full Text] [Related]
19. Matrix metalloproteinase genes are associated with breast cancer risk and survival: the Breast Cancer Health Disparities Study. Slattery ML; John E; Torres-Mejia G; Stern M; Lundgreen A; Hines L; Giuliano A; Baumgartner K; Herrick J; Wolff RK PLoS One; 2013; 8(5):e63165. PubMed ID: 23696797 [TBL] [Abstract][Full Text] [Related]
20. [Single nucleotide polymorphism in the matrix metalloproteinases promoter is associated with susceptibility to endometriosis and adenomyosis]. Kang S; Wang Y; Zhang JH; Jin X; Fang SM; Li Y Zhonghua Fu Chan Ke Za Zhi; 2005 Sep; 40(9):601-4. PubMed ID: 16202315 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]